Keyword: drugmaker


Sandoz Builds Biologics Plant in Slovenia

17.03.2023 -

Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia...


Novo Nordisk to Cut US Insulin prices from 2024

16.03.2023 -

Danish drugmaker Novo Nordisk has added its name to the list of insulin producers cutting prices for US retail buyers, following up on Eli Lilly’s announcement of price...


Sanofi Strengthens Venture Capital Budget

19.01.2023 -

As well as serving as a financial partner to fledgling companies, the VC fund supports future efforts for business development and M&A opportunities within its own...


Bayer Shifting Pharma Focus away from Europe

18.01.2023 -

Bayer is increasingly shifting the commercial focus of its pharmaceutical business away from Europe and toward the US and China, Stefan Oelrich, head of the German group...


US Opioid Settlement Talks in High Gear

17.10.2019 - Long anticipated bundled proceedings against opioid manufacturers and US opioid distributors began on Oct. 16 in a US court in Cleveland, Ohio, where cases against Israeli generics...


Pershing and Valeant Settle Allergan Lawsuits

05.01.2018 - Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...


GSK Expands Stake in Saudi Subsidiary

03.01.2018 - UK drugmaker GlaxoSmithKline (GSK) has expanded its stake in its Saudi subsidiary Glaxo Saudi Arabia Limited (GSAL) by 26% to 75%. With an investment of more than $243 million, the...


Teva Takes Back a few Job Cuts

03.01.2018 - After two weeks of protest in Israel, generics giant Teva has temporarily taken back about a third of the planned job cuts at its plant in Jerusalem. Original plans called for 340...